CRP and cancer: The most common blood test abnormality in patients with as-yet-undetected cancer was a raised inflammatory marker, with 74–79% of tested patients having at least one abnormal erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) result pre-diagnosis (Table 2).